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Background and Purpose  Hippocampal atrophy (HA) resulting from a central nervous 
system (CNS) infection might be a relevant lesion responsible for the clinical characteristics 
of medial temporal lobe epilepsy.
Methods  The clinical characteristics of 54 patients with CNS infection-related medial tempo-
ral lobe epilepsy (MTLE) with isolated HA (CNS infection group) and 155 patients with con-
ventional MTLE with HA (conventional group) were compared retrospectively. CNS infection 
alone and bilateral involvement of the HA were analyzed as prognostic factors, in addition to 
the detailed clinical characteristics, such as limbic aura and the presence and proportion of 
each type of automatism, between the two groups, and both medical and surgical prognoses 
were separately considered. A logistic regression analysis was performed.
Results  A statistical analysis including all clinical factors, including CNS infection with bi-
lateral HA, did not reveal significant differences between the two groups. An analysis compar-
ing the prognosis of the two groups based on good or poor prognosis among patients who re-
ceived medical treatment and good or poor outcomes among patients who received surgical 
treatment did not produce significant differences.
Conclusions  In addition to bilateral HA, CNS infection alone was not a poor prognostic factor 
for the CNS infection-related epilepsy with HA group compared with the conventional MTLE 
with HA group. Based on these negative results, HA is a plausible and relevant lesion with similar 
clinical characteristics to HA in patients with conventional MTLE. Therefore, CNS infection-re-
lated MTLE with isolated HA might represent another subtype of MTLE with HA with a differ-
ent etiology.
Key Words   central nervous system infection, medial temporal lobe epilepsy, 
hippocampal atrophy, brain MRI. 
Central Nervous System Infection-Related Isolated 
Hippocampal Atrophy as Another Subtype of Medial 
Temporal Lobe Epilepsy with Hippocampal Atrophy: 
A Comparison to Conventional Medial Temporal Lobe 
Epilepsy with Hippocampal Atrophy
INTRODUCTION
Medial temporal lobe epilepsy (MTLE) is a discrete syndrome or group of clearly distinct 
syndromes1 with different clinicopathological and electrophysiological characteristics. When 
combined with hippocampal atrophy (HA) as the most important hallmark of MTLE, MTLE-
HA is recognized as a distinct syndrome, representing a subtype of MTLE.2 The great ma-
jority of these patients have a history of complicated febrile convulsions or other initial pre-
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patients.5-8 Based on accumulating evidence from MRI and 
pathological studies, FS is the most plausible cause of HA.2,9,10 
Thus, FS may predispose affected individuals with MTLE to 
HA. Several cytokines and proinflammatory signaling path-
ways play roles in both experimental models and clinical 
cases of epilepsy.11-13 Fever involves inflammatory mediators 
such as the cytokines tumor necrosis factor-α and interleukin-
1β14,15-17 that promote neuronal hyperexcitability,18 and proin-
flammatory cytokines are implicated in seizure disorders.19-21 
A pathological study reported the overexpression of nuclear 
factor kappa-light-chain-enhancer of activated B cells, a tran-
scription factor, during acute inflammation in patients with 
temporal lobe epilepsy,22 suggesting that inflammation might 
be involved in the underlying mechanism of epilepsy.
However, the cause-and-effect relationship remains contro-
versial. HA occurs in a large percentage of patients (approxi-
mately 70%) with MTLE without evidence of FS,18 and pop-
ulation-based prospective studies of FS have not provided 
evidence of any association.21,23-25 To date, many patients with 
MTLE have been reported to have a history of FS, whereas 
some patients with MTLE-HA do not. These observations 
have sparked a debate concerning the etiology of HA,18 which 
does not appear to be caused by a single etiological factor.
A variety of other early precipitating insults, such as trau-
ma and infection, are also associated with MTLE.25,26 Brain 
infections are implicated in the etiology of at least 7% of all 
cases of epilepsy.27-29 According to some studies,18,22,30-33 im-
mune and inflammatory reactions occurring at birth or dur-
ing a patient’s lifetime might initiate a cascade of chronic in-
flammatory events in the central nervous (CNS) that contribute 
to late-onset epilepsy. An insult caused by CNS inflammation 
might damage any structure of the brain, and the temporal lobe, 
including the medial temporal structure, is often identified as 
a predisposing lesion in patients with CNS infection-related 
epilepsy,34 resulting in uncommon isolated HA.
HA in the brain is a well-known clinically and pathophys-
iologically relevant lesion observed in patients with conven-
tional MTLE. The involved networks of epileptogenesis after 
brain insult may differ due to varying underlying causes, un-
commonly resulting in HA. However, HA resulting from com-
mon probable epileptogenesis after febrile insults may share or 
reveal the clinical characteristics of epilepsy. If the clinical 
characteristics of CNS infection-related HA are not different 
from those of MTLE-HA without a history of CNS infection 
as conventional MTLE, then CNS infection-related HA might 
represent a subset of MTLE with a different etiology.
No study conducted to date has sufficiently answered this 
question. Therefore, we compared the clinical significance of 
HA between patients with CNS infection-related epilepsy and 
conventional MTLE by analyzing the clinical characteristics 




Two hundred nine patients with MTLE with HA were en-
rolled through a retrospective review of medical records from 
March 1994 to September 2017. MTLE with HA was de-
fined as follows: 1) a medical history compatible with histo-
ry of complicated febrile convulsion or other initial precipitat-
ing injury, 2) ictal semiology compatible with a limbic nature, 
3) ictal or interictal epileptiform discharge originating from 
the temporal lobe, and 4) HA on an MRI scan (refer to the 
detailed description of the criteria for MRI). Fifty-four of 
the 209 patients had a history of CNS infection, resulting in 
MTLE exhibiting isolated HA, and these patients were allo-
cated to the CNS infection group. Individuals presenting a 
simple febrile illness without a mental change or documen-
tation of cerebrospinal fluid profiles were not included. Thir-
ty-seven of the 54 patients in the CNS infection group had 
received medical treatment from the corresponding author, 
and the remaining 17 patients, who were referred, met the 
aforementioned inclusion criteria. Twenty-nine patients were 
confirmed to be diagnosed with herpes simplex encephali-
tis, and 5 patients were diagnosed with tuberculous menin-
gitis. The diagnoses of the other patients were ascertained 
by clear medical documentation of encephalitis, although 
the etiologies were unclear. One hundred fifty-five patients 
with MTLE with isolated HA were enrolled. None of these 
patients had a medical history of the aforementioned CNS 
infections. These patients were designated the conventional 
MTLE group. The history of FS was documented in detail in 
terms of the nature of the simple or complex febrile event. The 
presence of seizure at the time of CNS infection, which was 
differentiated from FS, was documented. Interictal epilepti-
form discharges from medial temporal areas were confirmed 
in an electroencephalogram with additional nasopharyngeal 
electrodes, which was regularly performed every 2 years in 
most all patients. Seventeen patients (31.5%) in the CNS in-
fection group and 62 (40%) patients in the conventional group 
underwent tailored temporal lobectomy with amygdalohip-
pocampectomy. The epileptic focus in the patients who had 
undergone surgical resection was confirmed through the ep-
ilepsy surgery program at our hospital.35 
This study was approved by and adhered to the guidelines 
established by our hospital’s Human Research Protection Cen-
ter (rms2 No; 2018-31-0925, irb; 2015-0925-004).
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MRI and clinical characteristics
Initial MRI examinations were performed using a 1.5-Tesla 
scanner and follow-up MRI examinations were performed 
using a 3.0-Tesla scanner in most all patients who were mon-
itored in the out-patient clinic. The diagnostic criteria for HA 
on the brain MRI included an increased signal on T2-weighed 
fluid-attenuated inversion recovery images and atrophy of the 
hippocampus on T1-weighted images with 3-dimensional vol-
ume acquisition in oblique coronal images and on T1-
weighted axial images. HA was qualitatively confirmed in 
the brain MRI by one neuroradiologist and one expert epi-
leptologist who were blinded to the patient’s medical history. 
Patients with non-HA lesions, including associated atrophy of 
the temporal lobe, were excluded. Demographic data, such 
as sex, age at the onset of epilepsy, and symptom duration, 
were compared between the CNS infection and convention-
al groups. Symptom duration was defined as the age of epi-
lepsy onset to the age of registration. Antecedent etiologies of 
epilepsy, including perinatal insult, complex FS, family history 
of epilepsy, and head trauma with loss of consciousness, were 
compared between the two groups. Semiological character-
istics of TLE, such as aura and automatism, were also analyzed. 
If the primary feature of the aura was limbic in nature, even in 
combination with nonspecific aura, then it was regarded as 
limbic aura. Automatism was divided into four categories: 
oropharyngeal, gestural, verbal, and wandering types. The 
proportion of each type and presence of multiple types of au-
tomatism in each patient were analyzed among the patients 
showing automatism. General characteristics of seizures, such 
as accompanying secondary generalized tonic-clonic (GTC) 
seizures, clustering nature, and nocturnal predominance, were 
analyzed. The definition of clustering36 was a closely grouped 
series of seizures or an increase over the patient’s typical sei-
zure frequency. Nocturnal predominance was defined as more 
than 90% of habitual seizures occurring during sleep. Left, 
right, and bilateral HA on MRI were also compared to assess 
laterality.
Prognostic criteria for the medical and surgical 
treatments
Medical and surgical prognoses were separately analyzed. The 
medical prognosis was categorized as seizure-free and year-
ly, monthly, weekly, and daily attacks based on the mean fre-
quency of seizure events in patients during the study period, 
which was counted for 3 years at the end point of study in pa-
tients with reliable compliance with antiepileptic drug (AED) 
treatment. Monthly attacks were defined as more than 4 sei-
zures per month. Twelve to 50 seizure attacks per year and 
less than 12 seizure attacks per year were regarded as ‘weekly 
attacks’ and ‘monthly attacks,’ respectively. In the patients 
with a clustering nature, the total number of seizure attacks 
during clustering events was considered. Patients who were 
‘seizure-free’ or experienced ‘yearly attacks’ had good out-
comes, whereas other patients were classified as having poor 
outcomes. The minimum duration of follow-up after the sur-
gery was based on at least 2 years. Seizure outcomes were 
assessed according to Engel’s classification37 [class I, seizure-
free; class IA, no disabling seizures; class II, rare seizures 
(fewer than three seizures per year); class III, worthwhile im-
provement (reduction in seizure frequency of 80% or more), 
class IV, no benefit]. Engel’s classes I and II were considered 
good outcomes, and Engel’s classes III and IV were consid-
ered poor outcomes. The mean number of AEDs adminis-
tered as part of medical treatment was compared between 
the two groups at the decision point based on the aforemen-
tioned prognostic criteria.
Statistical analysis
Unpaired T-tests were used to compare the demographic char-
acteristics of the subjects, and the chi-square test was used to 
compare the clinical characteristics of seizures, HA laterality 
on the brain MRI, and surgical and medical prognoses be-
tween the two groups. A univariate logistic regression analysis 
was performed to reveal the prognostic covariates. For the 
prognostic covariates, multiple logistic regression tests were 
conducted to identify the prognostic factors in all patients to 
correct for the effect of the group. Statistical analyses strati-
fied according to the prognostic criteria of medical and sur-
gical treatments were compared between two groups. SAS 
software (version 26.0, SAS Institute, Cary, NC, USA) was 
used for the statistical analyses.
RESULTS
The overall mean age at epilepsy onset was 19.1±14.8 years 
and 17.8±11.5 years in the CNS infection group and the con-
ventional group, respectively (Table 1). However, among the 
patients receiving medical treatment alone (Table 2), the 
mean age at epilepsy onset of patients with unilateral HA in 
the CNS infection group was 16.3±13.7 years (29.4±26.3 
years for bilateral HA) and 19.9±16.9 years for patients in 
the conventional group. The overall symptom duration was 
10.1±9.4 years and 12.2±11.2 years in the CNS infection and 
the conventional group, respectively. Significant differences 
in these demographic data were not observed between the 
two groups (Table 1). The overall mean age at infection was 
13.7±11.6 years in the CNS infection group and the latent pe-
riod was 5.5±5.8 years. When considering patients who only 
received medical treatment (Table 2), the mean age of the 
CNS infection group with unilateral HA was 10.4±9.8 years 
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with a latent period of 6.2±7.8 years, but the mean age of the 
CNS infection with bilateral HA was 27.4±25.2 years with a 
latent period of 2.0±3.7 years. Among patients who under-
went surgery (Table 3), the mean age at epilepsy onset was 
14.5±13.8 years and 14.6±12.8 years in the CNS infection 
group and the conventional group, respectively. The mean age 
at CNS infection and the latent period were 6.9±5.7 and 7.5± 
6.9 years, respectively (Table 3). A history of seizure at the time 
of CNS infection was reported in 35 of 46 patients (76.1%) in 
the CNS infection group. The antecedent etiology, except for 
FS, did not significantly differ. Sixty-eight of the 155 patients 
(43.9%) in the conventional group experienced complex fe-
brile convulsions. Demographic data, including sex and age 
at epilepsy onset, did not show significant differences. In terms 
of the clinical characteristics of the seizures, significant differ-
ences in the proportion of aura, including limbic nature and 
automatism, were not observed between the two groups. The 
proportion and presence of multiplicity in each patient pre-
senting automatism were not significantly different between 
the two groups. Oropharyngeal automatism and a multiplic-




MTLE with HA group (n=54)
Conventional MTLE  
with HA group (n=155)
p*/p†
Demographic data
Sex (male:female), n 34:20 75:80 NS/NS
Mean age at CNS infection±SD (range), year 13.7±11.6 (0.1–61)
Mean age at epilepsy onset±SD (range), year 19.1±14.8 (1–62) 17.8±11.5 (1–69) NS/NS
Mean latent period from CNS infection to seizure onset, year 5.5±5.8 (3–15)
Mean duration of symptoms±SD (range), year 10.1±9.4 (5–12) 12.2±11.2 (4–16) NS/NS
Presence of seizures at the time of CNS infection, n (%) 35/46‡ (76.1)
Mean follow-up duration±SD (range), month 92.6±68.3 (36–198) 83.6±66.4 (37–201) NS/NS
Antecedents of epilepsy, n (%)
Febrile seizure 8 (14.8) 68 (43.9) <0.001/NS 
Perinatal insult 1 (1.9) 1 (0.6) NS/NS
Family history 3 (5.5) 5 (3.2) NS/NS
Head trauma 4 (7.4) 18 (11.6) NS/NS
Clinical characteristics of seizures, n (%)
Aura 40 (74.1) 119 (76.8) NS/NS
Limbic aura 25 (62.5) 81 (68.1) NS
Automatism 43 (79.6) 115 (74.2) NS/NS
Type§: oropharyngeal 39 (52.7) 88 (42.7) NS
Gestural 23 (31.1) 74 (35.9)
Verbal 9 (12.2) 27 (13.2)
Wandering 3 (4.1) 17 (8.3)
Multiplicity: one type 19 (44.2) 41 (35.7) NS
Two types 18 (41.8) 59 (51.3)
Three types 5 (11.6) 13 (11.3)
Four types 1 (2.3) 2 (1.7)
Secondary generalized tonic-clonic seizure 35 (57.1) 119 (80.3) NS/NS
Clustering nature 8 (12.2) 19 (15.4) NS/NS
Nocturnal dominancy 3 (10.2) 14 (11.1) NS/NS
Laterality of HA on the brain MRI, n (%)
Right 22 (40.7) 78 (50.3) <0.001/NS
Left 18 (33.3) 77 (49.7)
Bilateral 14 (25.9) 0 (0.0)
*Demographic data were compared using an unpaired t-test and the chi-square test was performed to compare the clinical characteristics of sei-
zures, †A binary logistic regression analysis with all the prognostic factors was performed, ‡The history of seizures at the time of CNS infection was 
not clear in eight of the 54 patients, §The proportion was calculated from the sum of each type in patients presenting automatism.
CNS: central nervous system, HA: hippocampal atrophy, MTLE: medial temporal lobe epilepsy, NS: not significant.
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Table 2. Medical prognosis based on the frequency of seizures for three years at the end point of study in patients with reliable compliance
Demographic data
CNS infection-related 
MTLE with HA group (n=37)
Conventional MTLE 
with HA group (n=93)
p*
Involvement of HA unil.    bil.
Sex (male:female), n 16:7 7:7 53:40
Laterality of HA on the brain MRI (left:right), n 8:15 14
Mean age at CNS infection±SD, year 10.4±9.8 27.4±25.2 0.000
Mean age at epilepsy onset±SD, year   16.3±13.7 29.4±26.3 19.9±16.9 0.000
Mean latent period from CNS infection to seizure onset, year   6.2±7.8 2.0±3.7 0.000
Mean duration of symptoms±SD, year 10.1±9.4 9.3±8.2 11.9±10.8 NS
Prognosis of 
unil./bil.
No. of AEDs 
unil./bil.
Prognosis No. of AEDs p†
Prognostic criteria: Involvement of HA
Good prognosis, n (%) NS
Seizure-free 7 (30.4)/2 (14.3) 2.0/3.4 32 (34.4) 1.6
Yearly 8 (34.8)/7 (50.0) 2.7/2.4 37 (39.8) 2.6
Poor prognosis, n (%)
Monthly 7 (30.4)/2 (14.3)  3.4/4.5 17 (18.3) 2.8
Weekly   1 (4.3)/3 (21.4) 4.0/4.5 7 (7.5) 3.3
Total 23 (100.0)/14 (100.0) 2.8/3.2   93 (100.0) 2.4
*Demographic data were analyzed using an unpaired t-test between patients in the CNS infection group stratified according to unilateral and bilater-
al involvement, †The chi-square test was used to compare the prognoses between the CNS infection and conventional groups.
AEDs: antiepileptic drugs, bil.: bilateral, CNS: central nervous system, HA: hippocampal atrophy, MTLE: medial temporal lobe epilepsy, NS: not signifi-
cant, unil.: unilateral.
Table 3. Surgical prognosis at two years of follow-up after epilepsy surgery
Demographic data
CNS infection-related
MTLE with HA group (n=17)
Conventional MTLE
with HA group (n=62)
p*
Sex (male:female), n 11:6 22:40
Laterality of HA on brain MRI (left:right), n 10:7 28:34
Mean age at CNS infection±SD, year 6.9±5.7
Mean age at epilepsy onset±SD, year 14.5±13.8 14.6±12.8 NS
Mean latent period from CNS infection to seizure onset, year 7.5±6.9
Mean duration of symptoms±SD, year 9.7±8.8 12.5±11.6 NS
F/U period after surgery±SD, month 57.4±43.1 53.4±42.9 NS
Prognostic criteria‡ (n=16§) (n=59§) p†
Good outcome, n (%)
Free I 10 (62.5) 35 (59.3)
Class IA 0 (0.0) 6 (10.2)
Class II 2 (12.5) 10 (16.9) NS
Poor outcome, n (%)
Class III 3 (18.7) 7 (11.8)
Class IV 1 (6.3) 1 (1.7)
Total 16 (100.0) 59 (100.0)
*Demographic data were compared using an unpaired t-test and the chi-square test was conducted to compare the clinical characteristics of sei-
zures, †The chi-square test was conducted to compare the overall prognosis between patients with CNS infection-related epilepsy and patients with 
conventional MTLE with HA, ‡Engel’s classification30, §The outcome of surgery was not recorded for one of 17 patients in the CNS infection group and 
3 of 62 patients in the conventional group.
CNS: central nervous system, HA: hippocampal atrophy, MTLE: medial temporal lobe epilepsy, NS: not significant.
ity of two different types of automatism were most common 
when the patterns from both groups were combined (Table 
1). The general characteristics of the seizures, such as sec-
ondary GTC, clustering nature, and nocturnal predominance, 
also did not differ between groups (Table 1). In terms of later-
ality on brain MRI, right HA was observed in 40.7% (22/54) 
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and 50.3% (78/155) of patients in the CNS infection and con-
ventional groups, respectively. Bilateral HA was observed in 
25.9% of patients (14/54) in the CNS infection group. Ex-
cluding bilateral HA in the CNS infection group, a significant 
difference was not observed between the two groups (Table 
1). When the responses to medical treatment were divided 
according to good and poor prognoses, the proportions of 
patients achieving a good prognosis were 65.2% and 65.3%, 
and the proportions of patients achieving a poor prognosis 
were 34.7% and 35.7% in the groups with unilateral and bi-
lateral HA, respectively. In the conventional group, the pro-
portions of patients with good and poor prognoses were 
74.2% and 25.8%, respectively. No difference was observed 
between the two groups among patients who received medi-
cal treatment. The mean number of AEDs was 3.0 and 2.4 in 
patients in the CNS infection group and the conventional 
group, respectively (Table 2). In terms of the surgical prog-
nosis, which was divided into good and poor outcomes, the 
proportions of patients achieving a good outcome were 75.0% 
and 86.4% in the CNS infection and the conventional groups, 
respectively. The proportions of patients in these two groups 
achieving a poor outcome were 25.0% and 13.5%, respectively. 
The comparison of surgical prognoses between the two groups 
did not reveal any significant difference (Table 3). A univari-
ate logistic regression analysis of all the clinical factors between 
the two groups did not reveal significant prognostic covariates 
and, naturally, multiple logistic regression analyses did not 
identify any significant prognostic factors between the two 
groups.
DISCUSSION
Experimental models11,20,38 and clinical studies39,40 suggest the 
likelihood of a common final pathway for the generation and 
propagation of seizures, although the clinical profiles of CNS 
infection might differ, depending on the underlying microor-
ganism. No differences have been revealed between the path-
ological findings of temporal lobectomy due to intractable sei-
zures after CNS infection and the pathological findings of typical 
HA,41 consistent with the results of other reports.42,43 Al-
though the mechanisms of epileptogenesis with different un-
derlying etiologies have not been clearly elucidated, patients 
with HA as a relevant lesion resulting from CNS infection-re-
lated epilepsy or as a main pathology of conventional MTLE 
showed similar clinical profiles in this study, which confirmed 
the probability of a common final pathway of epileptogenesis.
In terms of the antecedent etiology related to epilepsy, no dif-
ferences, except for FS, were observed between the CNS infec-
tion group and the conventional group in the present study. 
Controlled studies24 have shown that perinatal risk factors 
are not risk factors for complex partial seizures, consistent 
with the results of the present study. In terms of febrile ill-
ness, the nature of FS and seizure at the time of CNS infec-
tion in CNS infection group were easily differentiated in a 
timely manner. Because the ability to ascertain the complex 
nature of FS was limited in some patients due to the very old 
medical history, only the patients with clearly documented 
cases of the complex nature of FS were included in the con-
ventional group. Therefore, the proportion was lower than in 
other reports.5,8 Nonetheless, the proportion of patients with 
seizures at the time of CNS infection and the proportion of 
patients with FS in the conventional group were significantly 
higher than patients with the other antecedent etiologies in 
this study. Therefore, acute seizures caused by febrile insults 
in the brain may represent a plausible etiological mechanism 
of epileptogenesis in the medial temporal structure, particu-
larly in the hippocampus.
In terms of the clinical characteristics of TLE, the preva-
lence of aura in the two groups was consistent with other re-
ports.3 The proportion of patients with limbic aura was also 
not significantly different between the two groups, and an epi-
gastric rising sensation was the most commonly observed in 
both groups (data not shown), consistent with other reports 
of MTLE.23,44-46 The pattern and proportion of automatism 
were similar between the two groups, which was also consis-
tent with other studies.46,47 A statistical analysis including all 
the clinical factors, including CNS infection as a plausible 
negative prognostic factor, suggested the presence of similar 
demographic and clinical characteristics between the two 
groups. An analysis of the prognosis between the two groups 
based on good or poor prognosis among patients who received 
medical treatment and good or poor outcomes among pa-
tients who received surgical treatment did not reveal signifi-
cant differences, and the proportions of seizure-free patients 
who received medical treatment in the two groups were not 
substantially different from the values reported in a study 
with 27.3 years of follow-up.48 Based on the shorter duration 
for the development of epilepsy with a mean of only 2 years 
and the lower proportion of seizure-free patients in the CNS 
infection group with bilateral HA than among patients with 
unilateral HA, bilateral HA appeared to indicate a poor prog-
nosis. Nevertheless, the overall prognosis of patients receiving 
medical treatment was not significantly different, indicating 
that bilateral HA was not a poor prognostic factor in this study. 
A greater number of AEDs was needed to achieve a similar 
medical prognosis in patients with bilateral HA than in the 
patients with unilateral HA in the CNS group. Symptom dura-
tion, which has been reported as a strong negative prognostic 
factor,49,50 was not considered a prognostic covariate due to the 
lack of a significant difference between the two groups. Inter-
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estingly, the age at epilepsy onset in patients in the CNS infec-
tion group with bilateral HA was significantly older than pa-
tients with unilateral HA, but the prognostic significance was not 
clear. However, an inevitable limitation was associated with 
the visual analysis of MRI, particularly the bilateral HA, and a 
3-dimensional volumetric analysis of the asymmetry of HA 
might provide more detailed information about the bilateral 
involvement of HA, which would provide more reliable results. 
In conclusion, significant differences in the clinical char-
acteristics or overall prognosis were not observed between 
patients with HA arising from a CNS infection or conven-
tional MTLE-HA. CNS infection alone and bilateral HA 
within the CNS infection group were not negative prognostic 
factors between the two groups. Based on these results, HA 
might be attributed to the relevant lesion of MTLE with a 
common epileptogenic pathway due to an underlying febrile 
insult, which was a common event in both the CNS infection 
and conventional groups.
In terms of classifying MTLE based on symptomatic local-
ization-related epilepsy, CNS infection-related MTLE-HA 
might be regarded as another subtype of MTLE with HA with 
a different underlying etiology.14 Further studies of patients 
with different etiologies, including patients with nonlesional 
MTLE, may provide more conclusive results.
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